Cited by

• Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.

  Tsukada J, Tahara A, Tomura Y, Wada Ki, Kusayama T, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A. Tsukada J, et al. Br J Pharmacol. 2001 Jul;133(5):746-54. doi: 10.1038/sj.bjp.0704117. Br J Pharmacol. 2001. PMID: 11429400 Free PMC article.
• Pharmacological characterization of F-180: a selective human V(1a) vasopressin receptor agonist of high affinity.

  Andrés M, Trueba M, Guillon G. Andrés M, et al. Br J Pharmacol. 2002 Apr;135(7):1828-36. doi: 10.1038/sj.bjp.0704634. Br J Pharmacol. 2002. PMID: 11934825 Free PMC article.
• 125I-8-L-arginine vasopressin binding to human mononuclear phagocytes.

  Block LH, Locher R, Tenschert W, Siegenthaler W, Hofmann T, Mettler E, Vetter W. Block LH, et al. J Clin Invest. 1981 Aug;68(2):374-81. doi: 10.1172/jci110265. J Clin Invest. 1981. PMID: 6267102 Free PMC article.
• Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets.

  Siess W, Stifel M, Binder H, Weber PC. Siess W, et al. Biochem J. 1986 Jan 1;233(1):83-91. doi: 10.1042/bj2330083. Biochem J. 1986. PMID: 3006664 Free PMC article.
• Desmopressin: in adults with nocturia.

  Cvetković RS, Plosker GL. Cvetković RS, et al. Drugs. 2005;65(1):99-107; discussion 108-9. doi: 10.2165/00003495-200565010-00008. Drugs. 2005. PMID: 15610055 Review.